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Background: To assess the effectiveness of emergency vaccination for reducing the contact-induced infection and
pathological damage caused by the highly pathogenic porcine reproductive and respiratory syndrome virus
(HPPRRSV), Twenty pigs were equally divided into four groups. Groups 1, 2 and 3 were housed in one unit, whereas
Group 4 was separately housed. Group 1 was challenged with HPPRRSV on day 0. Group 2 and 4 did not receive
treatment and were used as the contact-infected and uninfected controls, respectively. Group 3 was treated with
the attenuated vaccine at 0 days post-inoculation. The rectal temperatures, clinical signs, pathologic lesions and
viraemia of the piglets were detected and evaluated.
Results: The vaccinated pigs in Group 3 showed less clinical morbidity, viraemia, temperature fluctuations and lung
lesions at 14 days post-inoculation, as compared with the contact-infected (Group 2) and experimentally infected
(Group 1) pigs. Higher serum IFN-γ levels were detected among the pigs that received emergency immunisation.
Thus, IFN-γ may be involved in immunity against HPPRRSV infection.
Conclusions: These results indicated that emergency vaccination could effectively alleviate HPPRRSV infection
during experimental contact exposure. Our findings provide a novel and useful strategy for controlling clinical
HPPRRSV.Background
The highly pathogenic porcine reproductive and respiratory
syndrome virus (HPPRRSV) in China was first reported in
2006; the outbreak overwhelmed ten provinces (including
autonomous cities or regions) with more than 2,000,000
infected pig within the first four months [1]. HPPRRSV was
likewise reported in Vietnam, where it caused much eco-
nomic loss to local farms [2]. Thus, HPPRRSV has emerged
as one of the most important pathogens that threaten pig
farms.
An HPPRRSV-derived attenuated vaccine was developed
to control the disease [3]. The attenuated vaccine of a
modified-live virus (MLV) derived from the American
PRRSV VR-2332 has been widely used in PRRSV-prevalent
countries, with its safety and effectiveness proven by previ-
ous studies [4,5]. However, clinical observations showed* Correspondence: nwafucrb@gmail.com; wxlong@nwsuaf.edu.cn
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reproduction in any medium, provided the orthat several MLV-vaccinated farms in China suffered from
heavy economic losses caused by HPPRRSV in 2006 to
2010 [6]. This inconsistency revealed that the MLV vaccine
provides limited protection from HPPRRSV under normal
immunisation procedures.
Several farms in Jiangsu, China successfully reduced
HPPRRSV damage using a promising emergency immun-
isation strategy with the MLV strain. An excess dose of the
MLV vaccine (4 to 6 doses) was administered upon con-
firmation of HPPRRSV infection. Losses were reduced by
30% to 70%, as compared with the untreated herds (unpub-
lished data). Vaccine intervention against typical PRRSV
has been previously studied. Although not as effective as a
cure, vaccine intervention could reduce the persistence and
transmission of PRRSV in a pig population infected with
the heterogonous isolates [5,7].
This study aimed to replicate clinical cases under ex-
perimental conditions to confirm the effects of emer-
gency immunisation, which may be widely used for
emergency cases of HPPRRSV infection.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Rectal temperature of the pigs with different
treatment. The data was presented as the mean ± S.D.
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Virus
The Northern American PRRSV isolate BB0907 was
obtained from infected pigs in 2009, purified, and pas-
saged using MARC-145 cells. The BB0907 isolate (9th
passage on MARC-145) is highly virulent and caused high
mortality in piglets in previous experimental infection
experiments [8]. The widely used vaccine Ingelvac&reg
PRRS MLV was purchased from Ingelvac.
Animals
A total of 20 PRRSV-free crossbred (Landrace × local
stock) pigs, approximately 28-days-old, were randomly dis-
tributed into four groups. Groups 1, 2 and 3 were housed
in one unit, whereas Group 4 was housed in another.
All experimental procedures were approved by an inde-
pendent animal care and use committee. The guidelines of
the National Veterinary Research and Quarantine Service
for the reproduction of pathogenesis in pigs were respected.
Infection and immunisation
The Group 1 pigs were intramuscularly injected with
2×104 TCID50/ml BB0907 in 2 ml Dulbecco’s modified
Eagle’s medium at 0 day post-inoculation (DPI). The Group
3 pigs were intramuscularly vaccinated with three doses of
IngelvacW PRRS MLV (105 TCID50/ml) at 0 DPI. The pigs
in the Groups 2 and 4 did not receive any treatment.
Clinical and pathologic examination
Rectal temperatures, clinical signs, pathologic lesions and
viraemia were detected and evaluated following the proce-
dures of our previous study [9]. Sera were collected at 0, 3,
5, 7, 10, 14 and 21 DPI to detect the virus load, serum IFN-
γ concentration and PRRSV-specific antibody. At 3, 5, 7, 14
and 21 DPI, the following clinical signs were graded using a
scale from 0 to 1: anorexia, lethargy, rough hair, dyspnoea
and cough. Gross lung lesions (0 to 2 points) were evalu-
ated based on gray mottling, oedema and consolidation.
The severity of haemorrhage and the enlargement of lymph
nodes were scored using three grades (0 to 2 points). All
pigs were euthanised and necropsied on 21 DPI. Lung sec-
tions for histopathologic examination were collected and
prepared, as previously described [10]. Lung histopathology
was determined in terms of the degree of haemorrhage
(0 to 1 point) and interstitial pneumonitis (0 to 1 point).
The highest pathologic lesion score for the morbid pigs was
12 (total score of all the pathologic lesions).
Antibody measurement
Enzyme-linked immunosorbent assay (ELISA) S/P (Sam-
ple/Positive) ratios were determined using the HerdCheckW
PRRS ELISA 2×R (IDEXX Laboratories, Inc., Westbrook,
ME, USA) according to the manufacturer’s instructions.
The sera were collected on 0, 3, 5, 7, 10, 14 and 21 DPI.Serum IFN-γ concentration
To detect IFN-γ production in pigs, serum was collected
at 0, 3, 5, 7, 14 and 21 DPI for quantitative measurement
of IFN-γ using commercial ELISA kits (R&D Systems,
Minneapolis, MN, USA), according to the recommended
protocol. The test had three replicates for each sample,
and the data were presented as the mean ± S.E.
Viraemia detection
Viraemia was determined at 0, 3, 5, 7, 14 and 21 DPI by
real-time polymerase chain reaction amplification using
HPPRRSV-specific primers, as previously described [11].
To quantify the serum virus load, cDNA from cultured
PRRSV (with a known TCID50) was serially diluted by ten-
fold to generate a standard curve. The amount of virus in
the samples was determined by linear extrapolation of the
Ct value plotted against the standard curve.
Statistical analysis
All data are presented as mean ± S.D. χ2-test was used to
analyze the clinical signs and gross lesions of the animals
after challenge. The cytokines and viremia data were evalu-
ated using one-way repeated measurements ANOVA and
least significance difference. Differences with p < 0.05 were
considered statistically significant.
Results
Clinical signs and pathologic examination
All pigs exposed to BB0907, except those in Group 3,
exhibited high fever (≥ 41°C) for more than five days
(Figure 1). The pigs in Group 3 had slight temperature var-
iations, with 2 pigs from this group experiencing a three-
day fever of approximately 40.5°C. Aside from the high
fever, the appearance of typical HPPRRSV-induced charac-
teristics was delayed for almost eight days in Group 3. As
expected, the pigs in Group 4 had no relevant temperature
changes throughout the duration of the experiment.
The clinical signs of HPPRRSV infection were observed
at 3, 5, 7, 10, 14 and 21 DPI; these included anorexia,
Table 1 Summary of infection and treatment results from piglets
Scores of clinical signs of each pig Scores of pathological lesions of each pig***
Groups Morbidity* Mortality** 3dpi 5dpi 7dpi 14dpi 21dpi 1# 2# 3# 4# 5# Mean ± SD
Group1 5/5 3/5 1.6 2.2 3.2 4.5 3.2 8 12 9 12 12 10.6±1.83a
Group2 5/5 2/5 1 2 2.4 3 2.25 7 8 12 12 7 9.2±2..4a
Group3 3/5 0/5 0 1.4 0.4 3.2 1.6 5 7 4 9 7 6.40±1.58b
Group4 0/5 0/5 0 0 0 0 0 1 2 0 0 0 1.00±0.89c
* indicates numbers of ill pigs/total numbers of pigs within a group;
** indicates numbers of died pigs/total numbers of pigs within a group;
*** indicates mean scores of the clinical signs of living pigs;
# labels the ear number of pigs within one group;
The different labeled letter “a,b,c” in the last line indicates significant difference between different groups (P < 0.05).
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Groups 1 and 2 exhibited anorexia, lethargy and reddened
skin from 5 DPI to 7 DPI. Among the pigs in these groups,
three had dyspnoea and cough at 7 DPI. At 10 DPI, 3 pigs
in Group 1 and 2 pigs in Group 2 had died. By contrast,
the pigs in Group 3 only demonstrated slight lethargy, and
none of the individuals died during the experiment. The
pigs in Group 4 likewise exhibited no clinical signs of infec-
tion. Significantly serious tissue lesions were observed in
Groups 1 and 2, as compared with those in Groups 3 and
4. These results are summarised in Table 1.
The euthanised pigs were necropsied, during which their
lungs and lymph nodes were examined. The results showed
that the most serious gross lesions were observed in
Groups 1 and 2, including gray mottling, oedema, lung
consolidation, haemorrhage and lymph node enlargement.
Only a few cases of minor gray mottling were observed in
Group 3, with very slight signs of oedema and lungFigure 2 Microscopic examination of infected lungs compared with th
of lungs in pigs from Group1 (a), Group 2 (b), Group 3 (d) and Group 4 (c)
microscope at 200-fold original magnifications.consolidation. The lungs of pigs in Group 4 were relatively
clean, with one pig having a slight congestion. Microscopic
lesions in the lungs were evaluated in terms of their septal
thickening and haemorrhage. Lungs of the virus-inoculated
pigs showed microscopic lesions characterised by some sep-
tal thickening and haemorrhage (Figure 2). Lungs collected
from Groups 1 and 2 showed severe haemorrhage and sep-
tal thickening, whereas lungs from Group 3 only exhibited
slight lesion. The lungs obtained from Group 4 were rela-
tively healthy (Table 1).
Antibody measurement
The humoral immune response to PRRSV measured by the
ELISA S/P ratios at 10 DPI showed that the average anti-
body titres of the virus-exposed groups exceeded the 0.4
cut-off for a positive result. By contrast, the control group
averages were negative and remained below 0.4 until 21e healthy ones on 21 DPI. Hematoxylin- and eosin- stained sections
on 21 DPI. Images were obtained on an Olympus BX-50 light
Figure 5 Sera IFN-γ levels detected by commercial ELISIA kit.
The sera were collected from the pigs (n=5) at 0, 3, 5,7, 10, 14 and
21 DPI. Data were presented as the mean value of triplicate samples
± S.D. * means significant difference between Group 2 and 3
(P<0.05).
Figure 3 Kinetics of antibody response to PRRSV detected by
commercial available ELISA kit. The serum samples (n=5) were
collected from 0 to 21 DPI as indicated. Data were presented as the
mean value of triplicate samples ± S.D.
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three groups (Figure 3).
Viraemia
The viraemia test demonstrated that the level of PRRSV
transcripts in Groups 1 and 2 were significantly higher
than that in Group 3 at both 7 and 10 DPI (p < 0.05)
(Figure 4). A study to detect persisted infection in emer-
gency immunised pigs should be conducted in future.
PRRSV transcripts were not detected in Group 4 (Ct ≥ 40,
data not shown).
IFN-γ secretion
High IFN-γ serum levels were observed in the pigs ex-
posed to the virus. The highest serum IFN-γ concentra-
tion was observed in Group 3, which was administered
the emergency vaccination. The higher IFN-γ levels lastedFigure 4 Detection of the virus load in sera of the pigs by SYBR
Green real-time PCR after challenge. Serum samples were
collected from living pigs in each group at different days post
infection. Data were presented as the mean value of triplicate
samples ± S.D. * means significant difference between Group 2 and
3(P<0.05).for approximately 14 DPI, and the peak was observed at
10 DPI (Figure 5).
Discussion
Emergency vaccination is a useful tool for controlling ani-
mal and human infectious diseases after exposure to patho-
gens, such as the foot-and-mouth disease virus (FMDV)
[12], the classical swine fever virus (CSFV) [13], and rabies
virus [14]. Emergency vaccination diminishes economic
losses by reducing morbidity and mortality, as well as virus
transmission. Post-exposure vaccination for typical PRRS
has significantly reduced the number of persistently
infected pigs at 127 DPI and reduced viral shedding to
within 97 DPI [5]. In the present study, emergency vacci-
nation successfully alleviated the clinical signs of HPPRRSV
infection and reduced the mortality rate. Emergency vacci-
nation was more efficient in controlling HPPRRSV, an
acute form of the disease with epidemiologic characteristics
that differed from typical PRRS.
The mechanism for emergency vaccination may be
related to a quick adaptive immune response to restrict
viral replication and proliferation, which could explain the
immune protection conferred by the C strain of CSFV [13]
and FMDV emergency vaccine [12]. Emergency vaccination
might induce innate immunity. During rabies vaccination,
the attenuated rabies virus spreads from the peripheral sites
of inoculation to the CNS tissues, and triggers the substan-
tial immune cell infiltration into the CNS. These cells had a
major function in the early containment of rabies viral
infections (i.e., cleaning rabies or preventing them from
entering the CNS), particularly through the production of
type I interferon [14]. If the attenuated rabies vaccines
entered the CNS after the wild-type rabies virus, the vacci-
nation would be ineffective [14,15]. Previous studies have
provided very little explanation on the mechanism of
PRRSV emergency vaccination. PRRSV variants possess
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munity, which appears similar with rabies vaccination.
Thus, we speculated that the attenuated PRRSV might
trigger an innate immune response that subsequently con-
trols HPPRRSV infection.
The significantly higher level of serum IFN-γ in the
vaccine-treated group at 10 DPI lasted until the end of the
experiment (21 DPI). This process probably influenced the
protection obtained by piglets from the vaccinated group.
In a previous report [16], a swine serum IFN-γ response
was detected immediately after PRRSV infection and lasted
for approximately 3 weeks. IFN-γ is important for control-
ling PRRSV infection [17]. IFN-γ could inhibit PRRSV rep-
lication more effectively than the type I interferon in vitro
[18,19]. Furthermore, no neutralizing activities were
detected in all of the serum samples (data not shown). This
observation underlines the protective function of IFN-γ
during the early stages of PRRSV infection.
The viral load in tissues of infected pigs under the
acute infection phase was one of indexes used to indi-
cate PRRSV pathogenicity. The more virulent the strain
is, the higher is the viral load in pigs [17]. In our study,
the serum viral RNA load was significantly lower in the
vaccinated group (p < 0.05) at 7 and 10 DPI. The sever-
ity of a clinical disease is highly associated with the viral
load [20]. Thus, the lower serum viral RNA load might
account for the minimal clinical signs and tissue lesions
observed in the vaccinated group.
In this study, we developed an HPPRRSV contact-
infection model by intramuscular infection. The infected
pigs exhibited higher levels of viraemia at 3 DPI, thereby
suggesting that the pigs transmitted the virus within 2
DPI, which may account for the rapid spread of the virus
in herds [21]. PRRSV transmission is primarily via the
respiratory route [22]. Our data indicated that the virus
from the inoculation sites rapidly reached the lungs.
Conclusions
To the best of our knowledge, this is the first report that
uses emergency vaccination to control HPPRRSV infec-
tion. The experiment demonstrated a reduction in vir-
aemia by approximately 90% at 7 DPI to 10 DPI. The
tissue lesions scores ranged from 10.6 to 6.4 and the
mortality from 3/5 to 0/5 during the HPPRRSV contact-
infection. These data may provide a useful reference for
future methods of clinical HPPRRSV control.
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